Correlation Between ATT and Tscan Therapeutics
Can any of the company-specific risk be diversified away by investing in both ATT and Tscan Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ATT and Tscan Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between ATT Inc and Tscan Therapeutics, you can compare the effects of market volatilities on ATT and Tscan Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ATT with a short position of Tscan Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of ATT and Tscan Therapeutics.
Diversification Opportunities for ATT and Tscan Therapeutics
-0.61 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between ATT and Tscan is -0.61. Overlapping area represents the amount of risk that can be diversified away by holding ATT Inc and Tscan Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tscan Therapeutics and ATT is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ATT Inc are associated (or correlated) with Tscan Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tscan Therapeutics has no effect on the direction of ATT i.e., ATT and Tscan Therapeutics go up and down completely randomly.
Pair Corralation between ATT and Tscan Therapeutics
Taking into account the 90-day investment horizon ATT Inc is expected to generate 0.22 times more return on investment than Tscan Therapeutics. However, ATT Inc is 4.55 times less risky than Tscan Therapeutics. It trades about 0.21 of its potential returns per unit of risk. Tscan Therapeutics is currently generating about -0.11 per unit of risk. If you would invest 2,211 in ATT Inc on August 27, 2024 and sell it today you would earn a total of 107.00 from holding ATT Inc or generate 4.84% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
ATT Inc vs. Tscan Therapeutics
Performance |
| Timeline |
| ATT Inc |
| Tscan Therapeutics |
ATT and Tscan Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with ATT and Tscan Therapeutics
The main advantage of trading using opposite ATT and Tscan Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ATT position performs unexpectedly, Tscan Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tscan Therapeutics will offset losses from the drop in Tscan Therapeutics' long position.The idea behind ATT Inc and Tscan Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| Tscan Therapeutics vs. Apellis Pharmaceuticals | Tscan Therapeutics vs. Iteos Therapeutics | Tscan Therapeutics vs. Day One Biopharmaceuticals | Tscan Therapeutics vs. Acumen Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.
Other Complementary Tools
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data |